CN Stock MarketDetailed Quotes

301370 GKHT Medical Technology

Watchlist

12.71
+0.33+2.67%

Market Closed Nov 7 15:00 CST

5.98BMarket Cap36.73P/E (TTM)

GKHT Medical Technology Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

Assets

Current assets

Money funds

40.82%880.43M

20.76%616.41M

36.32%788.14M

-18.73%507.85M

--625.2M

-12.84%510.44M

--578.14M

76.48%624.9M

54.80%585.63M

71.85%354.08M

Notes receivable and accounts receivable

-23.93%1.79B

-16.62%1.93B

-17.01%1.89B

-8.85%2B

--2.35B

-5.21%2.32B

--2.27B

-5.64%2.19B

-1.24%2.44B

-4.64%2.32B

-Notes receivable

-56.31%94.23M

4.61%122.46M

82.66%173.86M

130.03%207.78M

--215.68M

-6.88%117.06M

--95.18M

3.10%90.33M

107.24%125.71M

154.95%87.61M

-Accounts receivable

-20.65%1.69B

-17.75%1.81B

-21.36%1.71B

-14.81%1.79B

--2.13B

-5.12%2.2B

--2.18B

-5.98%2.1B

-3.97%2.32B

-6.92%2.24B

Other receivables (including interest and dividends)

40.44%182.33M

46.66%179.55M

15.95%159.16M

19.30%165.17M

--129.82M

-3.96%122.43M

--137.27M

8.19%138.46M

-7.30%127.47M

4.79%127.98M

-Other receivable

----

46.66%179.55M

----

-3.96%122.43M

--137.27M

8.19%138.46M

-7.30%127.47M

4.79%127.98M

Advance payment

-25.37%374.46M

6.77%528.66M

30.25%592.04M

17.40%550.47M

--501.77M

84.13%495.12M

--454.54M

59.69%468.88M

2.32%268.89M

14.46%293.62M

Inventories

-7.48%2.64B

-8.47%2.68B

-8.98%2.67B

-10.84%2.66B

--2.86B

1.62%2.92B

--2.94B

1.42%2.98B

2.53%2.88B

3.74%2.94B

Receivable financing

62.95%68.78M

-29.28%37.4M

-44.19%24.99M

163.40%95.87M

--42.21M

69.14%52.89M

--44.79M

28.88%36.4M

147.97%31.27M

48.30%28.24M

Other current assets

-20.04%216.8M

-5.25%242.17M

-39.86%156.02M

22.47%279.26M

--271.13M

5.14%255.6M

--259.44M

-21.84%228.01M

-4.34%243.09M

25.98%291.73M

Total current assets

-9.19%6.15B

-6.96%6.21B

-6.05%6.28B

-6.22%6.25B

--6.77B

1.51%6.68B

--6.69B

4.90%6.67B

3.97%6.58B

4.15%6.36B

Non Current assets

Fixed assets

----

1,538.08%553.14M

----

-12.89%33.77M

--36.26M

-8.88%37.68M

-7.64%38.76M

7.61%41.35M

Constru in process

----

117.02%394.78M

--388.27M

286.88%364.95M

1,224.38%181.91M

--94.33M

Intangible assets

2.12%114.18M

3.61%114.89M

6.93%107.8M

12.29%114.48M

--111.81M

14.06%110.89M

--100.81M

7.95%101.95M

0.82%97.22M

-1.14%94.44M

Development expenditure

--7.36M

--3.27M

----

Long deferred expense

154.93%8.86M

119.63%8.9M

-23.04%3.71M

-38.99%3.42M

--3.48M

-36.99%4.05M

--4.82M

-35.43%5.6M

-44.10%6.43M

-47.84%8.68M

Deferred tax assets

-10.28%59.91M

2.93%67.07M

1.16%60.85M

21.68%49.17M

--66.77M

49.80%65.16M

--60.15M

13.92%40.41M

46.33%43.5M

33.67%35.47M

Usufruct assets

5.44%45.8M

5.52%51.11M

8.21%55.97M

-26.97%45.72M

--43.44M

-28.10%48.44M

--51.72M

-24.70%62.61M

14.89%67.37M

29.62%83.14M

Other non current assets

-41.84%19.27M

-2.04%15.13M

16.79%25.09M

-42.14%13.9M

--33.13M

-44.01%15.45M

--21.49M

-15.33%24.03M

41.23%27.59M

33.27%28.38M

Total non current assets

16.20%796.43M

20.96%813.51M

21.54%806.46M

22.80%782.52M

--685.4M

45.33%672.54M

--663.52M

65.17%637.23M

70.44%462.78M

46.93%385.79M

Total assets

-6.86%6.95B

-4.40%7.02B

-3.56%7.09B

-3.69%7.04B

--7.46B

4.39%7.35B

--7.35B

8.35%7.31B

6.71%7.04B

5.91%6.74B

Liabilities

Current liabilities

Short term loan

-22.78%1.01B

-45.50%1.01B

-43.98%1.22B

-55.71%1.09B

--1.31B

-17.44%1.86B

--2.17B

2.91%2.45B

-0.02%2.25B

7.92%2.38B

Notes payable and accounts payable

-7.70%2.52B

-10.80%2.58B

-14.49%2.33B

0.05%2.49B

--2.73B

11.82%2.9B

--2.73B

3.84%2.49B

4.74%2.59B

0.44%2.4B

-Notes payable

-21.83%76.49M

-45.35%41.95M

22.55%106.71M

57.91%115.13M

--97.86M

165.57%76.77M

--87.07M

143.02%72.91M

-59.40%28.91M

-55.66%30M

-Accounts payable

-7.18%2.44B

-9.86%2.54B

-15.71%2.22B

-1.70%2.37B

--2.63B

10.09%2.82B

--2.64B

2.07%2.41B

6.64%2.56B

2.08%2.37B

Contract liabilities

-8.30%112.7M

-39.44%120.23M

-13.49%155.66M

-9.27%148.31M

--122.91M

33.65%198.53M

--179.93M

109.09%163.46M

32.98%148.55M

17.83%78.18M

Salaries payable

-65.70%8.31M

-25.75%18.25M

-25.93%13.71M

-4.14%23.61M

--24.22M

21.96%24.57M

--18.51M

5.97%24.63M

11.62%20.15M

12.48%23.24M

Taxs payable

-23.89%27.95M

-34.37%20.62M

7.33%36.03M

49.93%38.49M

--36.72M

21.43%31.42M

--33.57M

-48.98%25.67M

-24.03%25.88M

45.83%50.31M

Other payable (including interest and dividends)

15.76%461.49M

24.97%462.07M

39.96%453.26M

27.30%390.44M

--398.64M

21.44%369.74M

--323.84M

18.76%306.72M

12.48%304.47M

-6.89%258.26M

-Dividend payable

----

--55.1M

----

--181.81K

-Other payable

----

10.07%406.97M

----

21.51%369.74M

--323.84M

18.85%306.72M

12.41%304.29M

-6.95%258.08M

Non current liabilities due within one year

-0.52%76.69M

0.12%78.99M

80.31%138.43M

67.59%138.42M

--77.08M

25.84%78.9M

--76.77M

90.12%82.59M

110.94%62.7M

134.11%43.44M

Other current liabilities

-8.30%14.65M

-33.84%17.07M

-13.49%20.24M

-9.27%19.28M

--15.98M

33.65%25.81M

--23.39M

109.09%21.25M

32.98%19.31M

17.83%10.16M

Total current liabilities

-10.23%4.23B

-21.36%4.31B

-21.41%4.37B

-22.12%4.33B

--4.71B

1.12%5.49B

--5.55B

6.15%5.56B

4.21%5.42B

4.44%5.24B

Current liabilities

Long term loan

-19.07%182.47M

-11.15%182.47M

-24.47%136.53M

-15.67%136.53M

--225.46M

245.40%205.36M

--180.76M

--161.91M

--59.46M

----

Deferred tax liabilities

-84.79%1.9M

-87.47%1.73M

-73.84%3.92M

58.86%1.89M

--12.47M

--13.81M

--14.97M

--1.19M

----

Long term deferred income

-3.77%4.39M

-8.69%4.6M

-12.25%4.84M

-15.24%5.07M

--4.56M

-27.42%5.03M

--5.51M

-24.11%5.99M

3.26%6.94M

3.01%7.89M

Lease liabilities

63.38%15.11M

55.57%16.53M

73.52%18.05M

-43.73%9.1M

--9.25M

-40.75%10.62M

--10.4M

-45.18%16.16M

-14.66%17.93M

-35.31%29.49M

Total non current liabilities

-19.02%203.86M

-12.57%205.32M

-22.83%163.33M

-17.63%152.59M

--251.73M

178.50%234.84M

--211.65M

395.65%185.25M

204.14%84.32M

-33.45%37.37M

Total liabilities

-10.67%4.43B

-20.99%4.52B

-21.46%4.53B

-21.97%4.49B

--4.96B

3.83%5.72B

--5.77B

8.90%5.75B

5.26%5.51B

4.02%5.28B

Shareholders equity

Paid-in capital

0.00%470.6M

17.65%470.6M

--470.6M

0.00%400M

--400M

0.00%400M

Capital reserve funds

-0.01%1.14B

211.57%1.14B

211.59%1.14B

211.58%1.14B

--1.14B

-0.16%365.04M

--365.04M

-0.15%365.06M

0.09%365.61M

Surplus reserve funds

20.23%77.45M

--64.42M

23.44%64.42M

--64.42M

23.44%64.42M

21.52%52.18M

Retained profit

13.20%810.43M

11.98%773.58M

21.82%793.37M

22.54%765.76M

--715.93M

21.27%690.84M

--651.25M

21.05%624.92M

32.34%569.66M

37.93%516.26M

Less:Treasury stock

--50.1M

--11.03M

----

Shareholders equity without minority interests

2.40%2.45B

58.45%2.41B

66.67%2.47B

68.54%2.45B

--2.39B

9.57%1.52B

--1.48B

9.02%1.45B

12.01%1.39B

12.82%1.33B

Minority interests

-36.09%70.1M

-10.44%96.65M

-10.94%92.77M

-3.27%99.28M

--109.7M

-24.48%107.93M

--104.16M

-20.89%102.64M

14.61%142.9M

19.11%129.75M

Total shareholder equity

0.71%2.52B

53.88%2.51B

61.57%2.56B

63.81%2.55B

--2.5B

6.39%1.63B

--1.58B

6.37%1.56B

12.25%1.53B

13.35%1.46B

Total liabilityies and equity

-6.86%6.95B

-4.40%7.02B

-3.56%7.09B

-3.69%7.04B

--7.46B

4.39%7.35B

--7.35B

8.35%7.31B

6.71%7.04B

5.91%6.74B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Grant Thornton Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021
Assets
Current assets
Money funds	40.82%880.43M	20.76%616.41M	36.32%788.14M	-18.73%507.85M	--625.2M	-12.84%510.44M	--578.14M	76.48%624.9M	54.80%585.63M	71.85%354.08M
Notes receivable and accounts receivable	-23.93%1.79B	-16.62%1.93B	-17.01%1.89B	-8.85%2B	--2.35B	-5.21%2.32B	--2.27B	-5.64%2.19B	-1.24%2.44B	-4.64%2.32B
-Notes receivable	-56.31%94.23M	4.61%122.46M	82.66%173.86M	130.03%207.78M	--215.68M	-6.88%117.06M	--95.18M	3.10%90.33M	107.24%125.71M	154.95%87.61M
-Accounts receivable	-20.65%1.69B	-17.75%1.81B	-21.36%1.71B	-14.81%1.79B	--2.13B	-5.12%2.2B	--2.18B	-5.98%2.1B	-3.97%2.32B	-6.92%2.24B
Other receivables (including interest and dividends)	40.44%182.33M	46.66%179.55M	15.95%159.16M	19.30%165.17M	--129.82M	-3.96%122.43M	--137.27M	8.19%138.46M	-7.30%127.47M	4.79%127.98M
-Other receivable	----	46.66%179.55M	----	----	----	-3.96%122.43M	--137.27M	8.19%138.46M	-7.30%127.47M	4.79%127.98M
Advance payment	-25.37%374.46M	6.77%528.66M	30.25%592.04M	17.40%550.47M	--501.77M	84.13%495.12M	--454.54M	59.69%468.88M	2.32%268.89M	14.46%293.62M
Inventories	-7.48%2.64B	-8.47%2.68B	-8.98%2.67B	-10.84%2.66B	--2.86B	1.62%2.92B	--2.94B	1.42%2.98B	2.53%2.88B	3.74%2.94B
Receivable financing	62.95%68.78M	-29.28%37.4M	-44.19%24.99M	163.40%95.87M	--42.21M	69.14%52.89M	--44.79M	28.88%36.4M	147.97%31.27M	48.30%28.24M
Other current assets	-20.04%216.8M	-5.25%242.17M	-39.86%156.02M	22.47%279.26M	--271.13M	5.14%255.6M	--259.44M	-21.84%228.01M	-4.34%243.09M	25.98%291.73M
Total current assets	-9.19%6.15B	-6.96%6.21B	-6.05%6.28B	-6.22%6.25B	--6.77B	1.51%6.68B	--6.69B	4.90%6.67B	3.97%6.58B	4.15%6.36B
Non Current assets
Fixed assets	----	1,538.08%553.14M	----	----	----	-12.89%33.77M	--36.26M	-8.88%37.68M	-7.64%38.76M	7.61%41.35M
Constru in process	----	----	----	----	----	117.02%394.78M	--388.27M	286.88%364.95M	1,224.38%181.91M	--94.33M
Intangible assets	2.12%114.18M	3.61%114.89M	6.93%107.8M	12.29%114.48M	--111.81M	14.06%110.89M	--100.81M	7.95%101.95M	0.82%97.22M	-1.14%94.44M
Development expenditure	--7.36M	--3.27M	----	----	----	----	----	----	----	----
Long deferred expense	154.93%8.86M	119.63%8.9M	-23.04%3.71M	-38.99%3.42M	--3.48M	-36.99%4.05M	--4.82M	-35.43%5.6M	-44.10%6.43M	-47.84%8.68M
Deferred tax assets	-10.28%59.91M	2.93%67.07M	1.16%60.85M	21.68%49.17M	--66.77M	49.80%65.16M	--60.15M	13.92%40.41M	46.33%43.5M	33.67%35.47M
Usufruct assets	5.44%45.8M	5.52%51.11M	8.21%55.97M	-26.97%45.72M	--43.44M	-28.10%48.44M	--51.72M	-24.70%62.61M	14.89%67.37M	29.62%83.14M
Other non current assets	-41.84%19.27M	-2.04%15.13M	16.79%25.09M	-42.14%13.9M	--33.13M	-44.01%15.45M	--21.49M	-15.33%24.03M	41.23%27.59M	33.27%28.38M
Total non current assets	16.20%796.43M	20.96%813.51M	21.54%806.46M	22.80%782.52M	--685.4M	45.33%672.54M	--663.52M	65.17%637.23M	70.44%462.78M	46.93%385.79M
Total assets	-6.86%6.95B	-4.40%7.02B	-3.56%7.09B	-3.69%7.04B	--7.46B	4.39%7.35B	--7.35B	8.35%7.31B	6.71%7.04B	5.91%6.74B
Liabilities
Current liabilities
Short term loan	-22.78%1.01B	-45.50%1.01B	-43.98%1.22B	-55.71%1.09B	--1.31B	-17.44%1.86B	--2.17B	2.91%2.45B	-0.02%2.25B	7.92%2.38B
Notes payable and accounts payable	-7.70%2.52B	-10.80%2.58B	-14.49%2.33B	0.05%2.49B	--2.73B	11.82%2.9B	--2.73B	3.84%2.49B	4.74%2.59B	0.44%2.4B
-Notes payable	-21.83%76.49M	-45.35%41.95M	22.55%106.71M	57.91%115.13M	--97.86M	165.57%76.77M	--87.07M	143.02%72.91M	-59.40%28.91M	-55.66%30M
-Accounts payable	-7.18%2.44B	-9.86%2.54B	-15.71%2.22B	-1.70%2.37B	--2.63B	10.09%2.82B	--2.64B	2.07%2.41B	6.64%2.56B	2.08%2.37B
Contract liabilities	-8.30%112.7M	-39.44%120.23M	-13.49%155.66M	-9.27%148.31M	--122.91M	33.65%198.53M	--179.93M	109.09%163.46M	32.98%148.55M	17.83%78.18M
Salaries payable	-65.70%8.31M	-25.75%18.25M	-25.93%13.71M	-4.14%23.61M	--24.22M	21.96%24.57M	--18.51M	5.97%24.63M	11.62%20.15M	12.48%23.24M
Taxs payable	-23.89%27.95M	-34.37%20.62M	7.33%36.03M	49.93%38.49M	--36.72M	21.43%31.42M	--33.57M	-48.98%25.67M	-24.03%25.88M	45.83%50.31M
Other payable (including interest and dividends)	15.76%461.49M	24.97%462.07M	39.96%453.26M	27.30%390.44M	--398.64M	21.44%369.74M	--323.84M	18.76%306.72M	12.48%304.47M	-6.89%258.26M
-Dividend payable	----	--55.1M	----	----	----	----	----	----	--181.81K	--181.81K
-Other payable	----	10.07%406.97M	----	----	----	21.51%369.74M	--323.84M	18.85%306.72M	12.41%304.29M	-6.95%258.08M
Non current liabilities due within one year	-0.52%76.69M	0.12%78.99M	80.31%138.43M	67.59%138.42M	--77.08M	25.84%78.9M	--76.77M	90.12%82.59M	110.94%62.7M	134.11%43.44M
Other current liabilities	-8.30%14.65M	-33.84%17.07M	-13.49%20.24M	-9.27%19.28M	--15.98M	33.65%25.81M	--23.39M	109.09%21.25M	32.98%19.31M	17.83%10.16M
Total current liabilities	-10.23%4.23B	-21.36%4.31B	-21.41%4.37B	-22.12%4.33B	--4.71B	1.12%5.49B	--5.55B	6.15%5.56B	4.21%5.42B	4.44%5.24B
Current liabilities
Long term loan	-19.07%182.47M	-11.15%182.47M	-24.47%136.53M	-15.67%136.53M	--225.46M	245.40%205.36M	--180.76M	--161.91M	--59.46M	----
Deferred tax liabilities	-84.79%1.9M	-87.47%1.73M	-73.84%3.92M	58.86%1.89M	--12.47M	--13.81M	--14.97M	--1.19M	----	----
Long term deferred income	-3.77%4.39M	-8.69%4.6M	-12.25%4.84M	-15.24%5.07M	--4.56M	-27.42%5.03M	--5.51M	-24.11%5.99M	3.26%6.94M	3.01%7.89M
Lease liabilities	63.38%15.11M	55.57%16.53M	73.52%18.05M	-43.73%9.1M	--9.25M	-40.75%10.62M	--10.4M	-45.18%16.16M	-14.66%17.93M	-35.31%29.49M
Total non current liabilities	-19.02%203.86M	-12.57%205.32M	-22.83%163.33M	-17.63%152.59M	--251.73M	178.50%234.84M	--211.65M	395.65%185.25M	204.14%84.32M	-33.45%37.37M
Total liabilities	-10.67%4.43B	-20.99%4.52B	-21.46%4.53B	-21.97%4.49B	--4.96B	3.83%5.72B	--5.77B	8.90%5.75B	5.26%5.51B	4.02%5.28B
Shareholders equity
Paid-in capital	0.00%470.6M	17.65%470.6M	17.65%470.6M	17.65%470.6M	--470.6M	0.00%400M	--400M	0.00%400M	0.00%400M	0.00%400M
Capital reserve funds	-0.01%1.14B	211.57%1.14B	211.59%1.14B	211.58%1.14B	--1.14B	-0.16%365.04M	--365.04M	-0.15%365.06M	0.09%365.61M	0.09%365.61M
Surplus reserve funds	20.23%77.45M	20.23%77.45M	20.23%77.45M	20.23%77.45M	--64.42M	23.44%64.42M	--64.42M	23.44%64.42M	21.52%52.18M	21.52%52.18M
Retained profit	13.20%810.43M	11.98%773.58M	21.82%793.37M	22.54%765.76M	--715.93M	21.27%690.84M	--651.25M	21.05%624.92M	32.34%569.66M	37.93%516.26M
Less:Treasury stock	--50.1M	--50.1M	--11.03M	----	----	----	----	----	----	----
Shareholders equity without minority interests	2.40%2.45B	58.45%2.41B	66.67%2.47B	68.54%2.45B	--2.39B	9.57%1.52B	--1.48B	9.02%1.45B	12.01%1.39B	12.82%1.33B
Minority interests	-36.09%70.1M	-10.44%96.65M	-10.94%92.77M	-3.27%99.28M	--109.7M	-24.48%107.93M	--104.16M	-20.89%102.64M	14.61%142.9M	19.11%129.75M
Total shareholder equity	0.71%2.52B	53.88%2.51B	61.57%2.56B	63.81%2.55B	--2.5B	6.39%1.63B	--1.58B	6.37%1.56B	12.25%1.53B	13.35%1.46B
Total liabilityies and equity	-6.86%6.95B	-4.40%7.02B	-3.56%7.09B	-3.69%7.04B	--7.46B	4.39%7.35B	--7.35B	8.35%7.31B	6.71%7.04B	5.91%6.74B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	Unqualified opinion
Auditor	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	--	--	Grant Thornton Certified Public Accountants (Special General Partnership)	--	Grant Thornton Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

301370 GKHT Medical Technology

GKHT Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target